Biora: Report for the First Quarter 2003

STOCKHOLM, Sweden, April 25, 2003 (PRIMEZONE) -- Biora AB (publ):


                                1st Qtr   1st Qtr   Full Year
                                 2003      2002      2002
 Net sales, SEK million          34.6      35.0     129.7
 Operating result, SEK million    1.4      -1.0     -0.9
 Net result, SEK million          1.4      -0.7     0.7

- On April 7, 2003, Straumann Holding AG announced a public offer to the shareholders and warrant holders of Biora AB. Biora's Board of Directors unanimously recommends that Biora shareholders accept the cash offer of SEK 17 per ordinary share.

- Sales during the first quarter 2003 amounted to SEK 34.6 million (compared to SEK 35.0 million for the first quarter 2002).

- Significant negative impact on sales during the first quarter 2003 due to the decline in the U.S. dollar exchange rate compared to the first quarter 2002.

- Net income during the first quarter 2003 was SEK 1.4 million (compared to a net loss of SEK 0.7 million for the first quarter 2002).

- Net change in cash for the first quarter 2003 was SEK -4.2 million (compared to SEK -3.5 million for the first quarter 2002).

Biora develops, manufactures and sells biotechnology-based products to dentists. Its principal product, Emdogain(R)Gel, which is approved for sale in Europe, North America and Japan among others, naturally regenerates the tooth-supporting structure that the tooth has lost due to periodontitis. Biora's shares are listed on the "O-list" of the Stockholm Stock Exchange in Sweden.


For further information, please contact: 
Svante Lundell, CFO and Investor Relations, Biora
tel: +46 40-32 13 56 or +46 705 32 30 56

Donna Janson, President and CEO of Biora
tel: +46 40 32 12 28 

http://www.biora.com

Biora: Report for the First Quarter 2003

Tags